
Plasma is a valuable resource for many current and potentially new biological therapies. We rely upon our donors to provide this lifesaving resource and as such, CSL has an obligation to maximize the development and delivery of important products from this vital resource for the benefit of patients. Maximizing patient benefit through our yield and reliability programs for donated plasma continues to be an important, strategic area of focus for CSL as we strive to be the industry pacesetter.